Year: 2020
Type: review
Abstract: Microbiota have emerged as key modulators of both the carcinogenic process and the immune response against cancer cells, and, thus, it seems to influence the efficacy of immunotherapy. While most studies have focused on analyzing the influence of gut microbiota, its composition substantially differs from that in the lung. Here, we describe how microbial life in the lungs is associated with host immune status in the lungs and, thus, how the identification of the microbial populations in the lower respiratory tract rather than in the gut might be key to understanding the lung carcinogenic process and to predict the efficacy of different treatments. Understanding the influence of lung microbiota on host immunity may identify new therapeutic targets and help to design new immunotherapy approaches to treat lung cancer.
Source: Trends in cancer
Institutions: Instituto de Investigación Sanitaria Aragón, Hospital Clínico Universitario Lozano Blesa, Hospital Universitario Miguel Servet, Consejo Superior de Investigaciones Científicas, Instituto de Carboquímica, Universidad de Zaragoza, Fundacion Agencia Aragonesa para la Investigacion y el Desarrollo
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,000
OpenAlex ID: W2999992860
